Kiniksa Pharmaceuticals Ltd (KNSA) stock news · rev $677.6M
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
This KNSA news page leads with what Kiniksa Pharmaceuticals Ltd filed — not a scraped headline mill.
No cached 8-K sentence for KNSA yet. We will not pad this page with generic market recap.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the KNSA stock page; for the tape open the quote page.
KNSA stock news FAQ
What are KNSA's latest revenue and net income?
Latest cached Kiniksa Pharmaceuticals Ltd (KNSA) revenue for Dec 31, 2025 was $677.6M. Net income was $59.0M. Statements: https://lician.com/financials/knsa
How did KNSA revenue change from the prior cached period?
Cached Kiniksa Pharmaceuticals Ltd (KNSA) revenue was up 60.1% from $423.2M (Dec 31, 2024) to $677.6M (Dec 31, 2025). Statements: https://lician.com/financials/knsa
What is KNSA's market cap?
Kiniksa Pharmaceuticals Ltd (KNSA) market cap is $3.73B on the latest cached fundamentals snapshot.
What kind of company is KNSA?
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Where is KNSA stock news listed?
Cached stock news for Kiniksa Pharmaceuticals Ltd (KNSA) is listed at https://lician.com/news/knsa. Filings: https://lician.com/sec/knsa
Not investment advice.